IRIS
GURNARI, CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.379
AS - Asia 4.001
EU - Europa 2.246
SA - Sud America 658
AF - Africa 58
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.352
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.264
SG - Singapore 2.144
IT - Italia 818
HK - Hong Kong 545
BR - Brasile 529
RU - Federazione Russa 452
CN - Cina 409
VN - Vietnam 303
JP - Giappone 191
FI - Finlandia 173
GB - Regno Unito 154
DE - Germania 142
IE - Irlanda 119
FR - Francia 91
NL - Olanda 85
KR - Corea 84
IN - India 75
ID - Indonesia 68
AT - Austria 57
CA - Canada 50
MX - Messico 49
AR - Argentina 47
SE - Svezia 32
BD - Bangladesh 26
PL - Polonia 25
ES - Italia 22
TR - Turchia 22
EC - Ecuador 21
ZA - Sudafrica 19
IQ - Iraq 17
IR - Iran 16
PY - Paraguay 16
UA - Ucraina 14
MA - Marocco 13
CO - Colombia 12
VE - Venezuela 11
JO - Giordania 10
PH - Filippine 9
PK - Pakistan 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 7
CL - Cile 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
AL - Albania 6
AU - Australia 6
BE - Belgio 6
IL - Israele 6
BY - Bielorussia 5
EG - Egitto 5
GR - Grecia 5
KZ - Kazakistan 5
LT - Lituania 5
MY - Malesia 5
NP - Nepal 5
PE - Perù 5
RO - Romania 5
SA - Arabia Saudita 5
UY - Uruguay 5
AZ - Azerbaigian 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
HR - Croazia 4
PT - Portogallo 4
TH - Thailandia 4
BG - Bulgaria 3
CH - Svizzera 3
ET - Etiopia 3
KG - Kirghizistan 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AM - Armenia 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SV - El Salvador 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GY - Guiana 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
Totale 12.347
Salva come PNG Salva come JPEG
Città #
Singapore 894
Wilmington 656
Houston 603
San Jose 567
Hong Kong 540
Ashburn 301
Rome 264
Council Bluffs 223
Creede 182
Tokyo 181
Beijing 156
Los Angeles 147
New York 135
Helsinki 132
Santa Clara 129
Woodbridge 127
Fairfield 121
The Dalles 120
Dublin 112
Chandler 100
Ho Chi Minh City 99
Dallas 95
Moscow 79
Buffalo 73
Hanoi 65
Center 63
Milan 56
Seattle 52
Jakarta 51
Chicago 43
São Paulo 43
London 42
Medford 42
Nuremberg 41
Cambridge 38
Lauterbourg 34
North Bergen 31
Ann Arbor 29
Lappeenranta 29
Munich 29
Redondo Beach 27
Mexico City 26
Naples 25
Orem 24
Atlanta 23
Vienna 23
Frankfurt am Main 21
Boardman 20
Lawrence 20
Stockholm 20
Brooklyn 19
Montreal 19
Rio de Janeiro 19
Warsaw 19
Amsterdam 17
Dearborn 16
Hackensack 16
Haiphong 15
Salt Lake City 15
Brasília 14
Denver 14
Baghdad 13
Johannesburg 13
Belo Horizonte 12
Chennai 12
Da Nang 12
Parma 12
Kilburn 11
Palermo 11
Phoenix 11
Pune 11
Seoul 11
Amman 10
Bari 10
Bologna 10
Guangzhou 10
Las Vegas 10
Menlo Park 10
Poplar 10
Curitiba 9
Engelhard 9
Monte Porzio Catone 9
Mülheim 9
San Diego 9
Shanghai 9
Tashkent 9
Toronto 9
Washington 9
Campinas 8
Contagem 8
Guayaquil 8
Madrid 8
Miami 8
Turin 8
Ankara 7
Asunción 7
Brno 7
Guarulhos 7
Hyderabad 7
Istanbul 7
Totale 7.506
Salva come PNG Salva come JPEG
Nome #
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia 501
Early detection of IgH monoclonal rearrangenent in follicular spicules of the nose preceding multiple myeloma diagnosis. Case report and review of the literature 339
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols 339
Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes 315
The emerging role of measurable residual disease detection in AML in morphologic remission 302
Immunologia dei trapianti e trapianto di cellule staminali ematopoietiche 255
The Role of Forkhead Box Proteins in Acute Myeloid Leukemia 243
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study 226
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 215
ACUTE LEUKEMIA AND LATENT TUBERCULOSIS INFECTION IN ITALY: QUANTIFERON-TB TEST SCREENING IN A LOW TUBERCULOSIS INCIDENCE COUNTRY 199
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations 195
Applications and efficiency of flow cytometry for leukemia diagnostics 194
Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders 193
From bench to bedside and beyond: Therapeutic scenario in acute myeloid leukemia 172
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting 149
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia 141
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters 136
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia 128
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways 127
A complex clinical presentation of ultra-high risk acute promyelocytic leukemia: A case report and insights on management 126
Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia 126
Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy 122
Culprit or innocent bystander? The case of a new fast-moving hemoglobin J variant in a pregnant woman 121
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response 119
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression 113
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia 104
A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia 104
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics 102
The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia 99
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience 96
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide 95
Germline DDX41 mutations define a unique subtype of myeloid neoplasms 93
'We cannot paint them all with the same brush': the need for a better definition of patients with myelodysplastic syndromes for clinical trial design 92
Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding 92
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges 92
A fatal case of peritonitis due to colonic localization of acute myeloid leukemia 90
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 88
When Poisons Cure: The Case of Arsenic in Acute Promyelocytic Leukemia 88
Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project 87
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML 87
Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M 86
Have we reached a molecular era in myelodysplastic syndromes? 86
Donor selection for allogeneic hematopoietic cell transplant in a patient with JAK2 V617F primary myelofibrosis and SH2B3/LNK germline variant 85
Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia 85
The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies 84
What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children? 84
UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia 82
LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don't Make an Evidence 82
Leukemia cutis in a patient with acute myeloid leukemia undergoing Azacitidine-Venetoclax: case presentation and review of the literature 81
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare t-cell lymphoma: a clinical challenge 81
Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations 81
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 80
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia 78
Landscape of biallelic DNMT3A mutant myeloid neoplasms 78
Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT 78
Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease 78
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia 77
Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia 76
A study of Telomerase Reverse Transcriptase rare variants in myeloid neoplasia 74
Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder 74
Aplastic anemia: quo vadis? 74
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia 73
Personalized risk schemes and machine learning to empower genomic prognostication models in myelodysplastic syndromes 69
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies 69
Copper Deficiency 68
Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria 68
Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia 68
Molecular landscape of immune pressure and escape in aplastic anemia 67
Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation 65
Advances in the pathogenesis of FLT3 -mutated acute myeloid leukemia and targeted treatments 65
Allogenic haematopoietic stem cell transplantation in VEXAS: A review of 33 patients 65
The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood 65
Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia 65
Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia 63
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT 63
Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept 62
Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation 62
A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS 62
Comprehensive transcriptomic analysis of VISTA in acute myeloid leukemia: insights into its prognostic value 62
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT 62
T-cell large granular lymphocytic leukemia associated with inclusion body myositis 62
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia 61
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander? 61
STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype 60
The Renovated Face of EHA Classical Master Class: A Survey-based Evaluation on Behalf of the EHA Campus Working Group 59
Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution 59
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms 59
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments 59
Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes 58
Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia 57
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee 57
Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria 57
A multimodal analysis of genomic and RNA splicing features in myeloid malignancies 56
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms 56
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders 56
Clonal hematopoiesis in large granular lymphocytic leukemia 56
Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes 55
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT 55
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria 55
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome 54
Totale 10.584
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.464
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 21 5
2021/2022211 6 17 15 5 1 35 9 13 12 14 18 66
2022/20231.161 28 23 13 52 22 62 768 40 33 16 44 60
2023/2024670 91 37 51 45 67 121 70 47 35 36 12 58
2024/20253.647 52 489 248 162 49 162 252 372 453 378 566 464
2025/20265.547 455 377 661 485 459 254 800 753 761 480 62 0
Totale 13.061